Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Trial Evaluating Efficacy of Perioperative Organ Protection as Well as Safety of Ulinastatin Use in Pediatric Patients Undergoing Open Heart Surgery Through CPB to Treat Complex Congenital Heart Diseases

NCT02527811 is registered in ClinicalTrials.gov with Techpool Bio-Pharma Co., Ltd. as lead sponsor.

NCT NCT02527811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Trial Evaluating Efficacy of Perioperative Organ Protection as Well as Safety of Ulinastatin Use in Pediatric Patients Undergoing Open Heart Surgery Through CPB to Treat Complex Congenital Heart Diseases
Lead sponsor
Techpool Bio-Pharma Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2015
Completion date
December 31, 2018
Enrollment
450 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart diseases